GlassDollar connects leading corporations to cutting-edge startups to build the world of tomorrow

May 31, 2023

GlassDollar raises €2M (led by HTGF) to match startup solutions to corporate challenges and design the world of tomorrow.

  • Through data, software and operational support, GlassDollar provides a Venture Clienting OS that helps corporate innovators use startup solutions to achieve tangible impact — on their organization and the world.
  • Customers include leading innovation units at Bosch Siemens home-appliances, Volkswagen, A2A, LG, MTU and Infineon.
  • In March, GlassDollar closed a €2M Seed round led by HTGF.

Berlin, 31 May 2023 – Our world is rapidly changing, and with it the challenges facing large businesses. From reducing Co2 emissions to leveraging artificial intelligence to automate processes, designing a modern employee experience to attract talent, or wowing customers through superior support, corporations are asked to innovate in their products, their services and their processes in order to stay relevant.

Founded in Berlin in 2019, GlassDollar helps corporations become innovation leaders while staying focused on their core competencies. Instead of building a solution to every need from scratch, customers plug startup solutions into their infrastructure. For a fraction of the would-be in-house cost and time, they leverage hundreds of billions in VC funding and startup R&D to generate impact for their organization and the planet.

Supporting corporations’ transition towards sustainability, digitisation, new work and beyond is a massive lever to change the world, and we’ve decided to seize it.

Fabian Dudek, CEO of GlassDollar

GlassDollar exists to support corporations who are truly committed to innovation, and the entrepreneurs who are building solutions to the challenges of tomorrow

GlassDollar counts customers like BSH, Volkswagen, Infineon, LG, MunichRe, A2A and NEW, who rely on GlassDollar’s tooling and expertise to implement impactful change with selected startup solutions. Since 2019, their innovation units, supported by GlassDollar, have created an estimated:

  • 750 matches on topics such as Manufacturing 4.0, Sustainable Logistics, Improved Employee Experience, Omni-Channel data, Digitalisation and many more
  • 80M tons in Co2 reduction, by implementing solutions like Bio-Packaging or Optimised Logistics
  • €600M in bottom-line impact for corporations
  • €200M in startup revenue

In doing so, GlassDollar has already earned millions in revenue and has just raised a €2M round from HTGF, APX, Stefan Gross-Selbeck, Sigmar Gabriel, Gregor Stühler, Christian Lindener, Gleb Tritus, Miriam Wohlfarth, Alexander Tschirnhaus, Sascha Menges, Philipp Willigmann, Ole Tillmann, Michael Jäger, Kerim Galal, David Majert, Sascha Weiler.

This handpicked selection of investors comes to join early believers like Peter Borchers (founder hub:raum), Brigitte Zypries, Dietmar Harhoff (Max Planck Innovation), Matthias Notz & Claus Karthe (founder German Accelerator), Ulrich Huehner (ex CIO EnBW).

Team GlassDollar
Team of GlassDollar: from left to right Madlen Weinhardt (COO), Fabian Dudek (Founder & CEO), Kamen Kanev (Head of Engineering)

About GlassDollar
Through data, software and operational support, GlassDollar provides a Venture Clienting OS that helps corporate innovators use startup solutions to achieve tangible impact — on their organization and the world. GD, founded in 2019 by Fabian Dudek, makes impactful technology accessible to corporations and generates revenue for startups. Customers include leading innovation units at BSH, Volkswagen, A2A, LG, MTU and Infineon. GlassDollar is backed by HTGF and a select group of value-adding angels, including Sigmar Gabriel, Brigitte Zypries, Peter Borchers, and Stefan Gross-Selbeck.

Media contact

About High-Tech Gründerfonds  

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise, entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected more than 4.5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 160 companies. 
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. 

Media contact 
High-Tech Gründerfonds Management GmbH 
Stefanie Grüter, Partner Communications & Relations  
T.: +49 228 – 82300 – 188  

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

10. July 2024

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Papatheodorou moves from Chair of the Board to CEO of HepaRegeniX Dr. Linda Greenbaum joins HepaRegeniX as CMO Tuebingen (Germany), July 10, 2024 – HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapies for the treatment of acute and chronic liver diseases, today announced the closing of a Series C rou
9. July 2024

SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases.

The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy. Munich, Germany, July 9, 2024 – SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic iRhom2 antibodies, announced today the closing of a EUR 63 million (USD 70 million) Series A financing round. The round was co-led by Andera Pa